Navigation Links
Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
Date:5/25/2011

for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control.  QIAGEN's assay technologies include multiple companion diagnostics that are co-developed with its pharmaceutical partners. Companion diagnostics are used to predict in advance which patients are most likely to benefit from a particular therapy.

QIAGEN's portfolio encompasses the therascreen® EGFR RGQ PCR Kit (CE-IVD) available in Europe, as well as a broad panel of other biomarkers including KRAS, PI3K, BRAF for Research Use Only (RUO) or CE-IVD. The QIAGEN EGFR test is not available for routine clinical diagnostic use in the United States.

QIAGEN employs nearly 3,600 people in over 30 locations worldwide. Further information about QIAGEN can be found at www.QIAGEN.com.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operatio
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DARTâ„¢-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 2014  Decision Resources Group,s new Manhattan ... that online information and other value-added services ... their offering and support physicians. Physicians who ... rely on websites, mobile apps and other ... physicians are looking to manufacturers to provide ...
(Date:9/15/2014)... , Sept. 15, 2014 myMatrixx has extended ... Stanos with an expanded role that includes direct ... Dr. Stanos, a nationally recognized physiatrist and pain management ... to rehabilitation and workers, compensation, is Board Certified in ... American Board of Pain Medicine and subspecialty boarded by ...
(Date:9/15/2014)... Sept. 15, 2014  Catalist-listed QT Vascular Ltd. ("QT ... developer and manufacturer of minimally invasive medical devices for ... that the Group has enrolled the first European patients ... . Multiple patients have already been enrolled in this ... City Hospital, in Auckland, New Zealand ...
Breaking Medicine Technology:Physician device decision-makers show strong demand for device manufacturer digital content and support 2Physician device decision-makers show strong demand for device manufacturer digital content and support 3myMatrixx Announces Expanded Role for Medical Director Steven P. Stanos, Jr., DO 2First European Patients Enrolled in QT Vascular's ENDURE Trial 2First European Patients Enrolled in QT Vascular's ENDURE Trial 3First European Patients Enrolled in QT Vascular's ENDURE Trial 4First European Patients Enrolled in QT Vascular's ENDURE Trial 5
... , SACRAMENTO, Calif., Nov. 10 The Joint ... Ventricular Assist Device/Destination Therapy certification, allowing the Sacramento ... ventricular assist devices (LVADs) as permanent therapy and ... Medical Center, Sacramento is the only hospital in ...
... Stryker Corporation (NYSE: SYK ) announced today that ... technology firm. OtisMed will focus on customizable instrumentation ... that surgeons and patients realize from Stryker,s Triathlon Knee ... operate as part of Stryker,s Orthopaedics Division and remain ...
Cached Medicine Technology:Sutter Medical Center Receives Certification to Use Ventricular Assist Devices as Destination Therapy 2Stryker Announces Agreements To Acquire Assets 2Stryker Announces Agreements To Acquire Assets 3
(Date:9/15/2014)... 2014 Octo Consulting Group, a ... to the federal government, today announced it is ... Atlanta, Georgia to better serve existing and future ... is credited to the strong growth momentum of ... of management consulting, agile software development, data visualization, ...
(Date:9/15/2014)... By Randy Dotinga ... (HealthDay News) -- Patients prescribed cholesterol-lowering drugs are more ... if the medications are cheaper generic brands, new research ... as statins. Well-known brands include Crestor, Zocor and Lipitor. ... to lower the risk of heart problems due to ...
(Date:9/15/2014)... approximately one out of every 40 individuals in the United ... muscular atrophy (SMA), a neurodegenerative disease that causes muscles to ... have made a recent breakthrough with the development of a ... of the disease. In April, a patent was filed for ... lab is using to fight SMA is to ,repress the ...
(Date:9/15/2014)... Texas (PRWEB) September 16, 2014 ... key market data on the Canada Gynecological Devices ... US dollars, volume (in units) and average prices ... Female Sterilization Devices (Transcervical Sterilization ... and Rings) , Endometrial Ablation Devices ...
(Date:9/15/2014)... September 15, 2014 In order to ... medicine often act conjointly to quantify, define and model ... become an integral part of medical care. , The ... the studies conducted by the non-profit Institute of BioAcoustic ... demonstrated that math can be much more than a ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group Announces it is Opening Two New Offices in Alexandria, Virginia and Atlanta, Georgia to Better Serve Existing and Future Federal Government Clients 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 3Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 4Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3
... Video game makers are now looking to extend their reach beyond ... a really ripe market awaits them. For the aging population in ... water.// ,Leading games manufacturer, Nintendo has sold 3.3 million ... May last. "We wanted to reach out to those who were ...
... uses the construction abilities of tiny viruses to build ... batteries.// , MIT Professors Angela Belcher, Paula ... few genes within common laboratory virus strains were able ... functional electronic device. ,Batteries are made of ...
... Emirates are concerned with the proposal of the Ministry of ... the country.// ,"A committee has been set up ... provides for the private medical sector. This includes the licensing ... and the licensing of the medical or health establishments as ...
... Pink is angry that teenage girls are so obsessed with ... a sex tape.// ,According to contactmusic.com, Pink caused controversy ... in her song "Stupid Girls". But she says there is ... the popularity of Hilton's raunchy homemade film made with her ...
... Association, Les Woolard of Moree says that the Federal Government ... prepared to work in regional areas. // ,According to ... who live in Newcastle, Sydney and Wollongong there are six ... there is only one psychologist. ,He said that ...
... obesity is that the amount of junk food youngsters ... spend// watching television. Researchers analyzed the dietary and viewing habits ... , It was found that consumption of sweets and fizzy ... the idiot box. Researchers at the universities of Aberdeen and ...
Cached Medicine News:Health News:TV Viewing Increases Intake of Junk Food 2
... vascular closure device quickly seals ... procedures, allowing for early ambulation ... creates a mechanical seal by ... bio-absorbable anchor and collagen sponge, ...
These are coronary angiographic catheters used for selective coronary bypass angiography. The catheters curve configuration is ideally suited to select the internal mammary artery....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: